Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Sciatic Nerve Block vs Systemic Analgesia in PAOD
NCT02841488Phase 3Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
Phase 3, randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Pain intensity (Numerical Pain Scale) at 28 days. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
Beyond the preview
Go deeper on NCT02841488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841488.